Another CAF subset (CD10+ GPR77+) was identified in chemotherapy-resistant breast tumors, the targeting of which using a neutralizing anti-GPR77 antibody abolished tumor formation and restored tumor chemosensitivity of patient-derived xenografts [245]. This evidence concerns the gene MME and neoplasm.